1. Home
  2. ASPN vs DCTH Comparison

ASPN vs DCTH Comparison

Compare ASPN & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aspen Aerogels Inc.

ASPN

Aspen Aerogels Inc.

HOLD

Current Price

$5.31

Market Cap

429.3M

ML Signal

HOLD

Logo Delcath Systems Inc.

DCTH

Delcath Systems Inc.

HOLD

Current Price

$13.12

Market Cap

372.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASPN
DCTH
Founded
2001
1988
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
429.3M
372.5M
IPO Year
2011
2015

Fundamental Metrics

Financial Performance
Metric
ASPN
DCTH
Price
$5.31
$13.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$4.25
$22.00
AVG Volume (30 Days)
1.4M
444.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.53
EPS
N/A
N/A
Revenue
$271,103,000.00
N/A
Revenue This Year
N/A
$24.54
Revenue Next Year
$50.03
$33.15
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.30
$8.12
52 Week High
$9.78
$13.74

Technical Indicators

Market Signals
Indicator
ASPN
DCTH
Relative Strength Index (RSI) 45.09 59.24
Support Level $5.11 $10.10
Resistance Level $6.61 $13.74
Average True Range (ATR) 0.32 0.52
MACD -0.08 -0.03
Stochastic Oscillator 19.42 61.25

Price Performance

Historical Comparison
ASPN
DCTH

About ASPN Aspen Aerogels Inc.

Aspen Aerogels Inc is an aerogel technology company that designs, develops, and manufactures high-performance aerogel insulation used in the energy industrial and sustainable insulation markets. The company also conducts research and development related to aerogel technology, supported by funding from several agencies of the United States of America government and other institutions in the form of research and development contracts. It is engaged in two operating segment Energy Industrial and Thermal Barrier. Geographically, it operates in the U.S. and also has a presence in other International countries. It generates the majority of its revenue from the Thermal Barrier segment and the United States market. Some of its products include Pyrogel XTE, Cryogel Z, Spaceloft Subsea, and others.

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. The company is focused on the treatment of primary and metastatic liver cancers. The firm's product include Melphalan Hydrochloride, Hepzato for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.

Share on Social Networks: